Nephros (NEPH) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for Nephros (NEPH) over the last 15 years, with Q3 2025 value amounting to $10.6 million.
- Nephros' Shares Outstanding rose 78.28% to $10.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.6 million, marking a year-over-year increase of 78.28%. This contributed to the annual value of $10.5 million for FY2024, which is 41.12% up from last year.
- Per Nephros' latest filing, its Shares Outstanding stood at $10.6 million for Q3 2025, which was up 78.28% from $10.6 million recorded in Q2 2025.
- Nephros' Shares Outstanding's 5-year high stood at $10.6 million during Q3 2025, with a 5-year trough of $9.9 million in Q1 2021.
- Its 5-year average for Shares Outstanding is $10.4 million, with a median of $10.3 million in 2022.
- In the last 5 years, Nephros' Shares Outstanding soared by 1275.33% in 2021 and then fell by 6.2% in 2023.
- Over the past 5 years, Nephros' Shares Outstanding (Quarter) stood at $10.2 million in 2021, then rose by 0.97% to $10.3 million in 2022, then grew by 1.98% to $10.5 million in 2023, then rose by 0.41% to $10.5 million in 2024, then increased by 0.78% to $10.6 million in 2025.
- Its Shares Outstanding stands at $10.6 million for Q3 2025, versus $10.6 million for Q2 2025 and $10.6 million for Q1 2025.